#152534

Anti-ADAM19 [19MOCYT]

Cat. #152534

Anti-ADAM19 [19MOCYT]

Cat. #: 152534

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: ADAM19

Class: Polyclonal

Application: WB

Reactivity: Mouse

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Carl Blobel

Institute: Hospital for Special Surgery

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ADAM19 [19MOCYT]
  • Research fields: Cancer;Cell signaling and signal transduction
  • Clone: 19MOCYT
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: ~120 kDa
  • Reactivity: Mouse
  • Host: Rabbit
  • Application: WB
  • Description: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.
  • Immunogen: GST-fusion protein with the cytoplasmic domain of murine ADAM19

Target Details

  • Target: ADAM19
  • Molecular weight: ~120 kDa
  • Target background: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Whole serum
  • Storage conditions: -20° C
  • Shipping conditions: Dry ice

References

  • Chesneau et al. 2003. J Biol Chem. 278(25):22331-40. PMID: 12682046.
  • Inoue et al. 1998. J Biol Chem. 273(7):4180-7. PMID: 9461614.
  • Kawaguchi et al. 2007. J Cell Sci. 120(Pt 6):943-52. PMID: 17344430.
  • Zhou et al. 2004. Mol Cell Biol. 24(1):96-104. PMID: 14673146.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.